Pages with the fewest revisions
Showing below up to 50 results in range #451 to #500.
- 35. Cerebral edema, hydrocephalus, malformations of the brain (1 revision)
- Spinal disc herniation (1 revision)
- Colonoscopy (1 revision)
- 26. Protein folding, chaperones (1 revision)
- 16. Sleep apnoea (1 revision)
- 8B. Parkinson’s disease (1 revision)
- 36. Dementias and neurodegenerative disorders (1 revision)
- MR (1 revision)
- Congenital vesicoureteral reflux (1 revision)
- 27. Epidemiology and prevention of enteric bacterial infections (1 revision)
- B19. Lower urinary tract infections in women: Classification, pathogenesis, and management (1 revision)
- 9. Morbidity and mortality of malignant diseases (1 revision)
- 53. Drug treatment of neurodegenerative disorders (1 revision)
- B21. Threatened preterm delivery; pathomechanism, management (1 revision)
- A10. Blood transfusion (1 revision)
- 55. Deficiency anaemias (1 revision)
- Total hip replacement (1 revision)
- Naevus (1 revision)
- B26. Abnormalities of the fetal engagement (1 revision)
- 18A. Migraine and other primary headaches (1 revision)
- A13. The criteria and the potential complications of IUD usage (1 revision)
- 57. Adjuvant analgesics. Centrally-acting muscle relaxants (1 revision)
- 39. Radioisotope diagnostics of pulmonary embolism (perfusion and inhalation). Radioisotope methods in pulmonary malignancies. (1 revision)
- Ultrasonography (1 revision)
- Enteral and parenteral nutrition (1 revision)
- B3. Dermatomyositis (1 revision)
- 19. Pharmacology of protein and peptide mediators, the purinergic system and nitric oxide (1 revision)
- 10. Bowel obstruction (ileus) (1 revision)
- 59. Diseases of the upper airways (1 revision)
- Urticarial vasculitis (1 revision)
- Femoral shaft and distal femoral fracture (1 revision)
- B34. Urinary incontinence and urodynamic studies (1 revision)
- 2. Characterisation of agonist-receptor interaction. Occupancy, affinity, dose-response curve, potency, efficacy (1 revision)
- 10. T-cell activation and peripheral T-cell differentiation (1 revision)
- A20. The most frequent pyogenous infections (1 revision)
- 6. Epidemiology and prevention of cerebrovascular diseases (1 revision)
- 40. Glial central nervous system tumours (1 revision)
- 28. Indolent B cell lymphomas (FL, CLL, MCL, MZL) (+ introduction to haematological malignancies) (1 revision)
- Functional bowel disorder (1 revision)
- B44. Surgery of metastases (1 revision)
- 2. The fundamentals of CT and MRI imaging, examination methods. (1 revision)
- 11. Diseases of the aorta. Imaging methods, the role of CT and MRI. (1 revision)
- 60. Mesothelioma (1 revision)
- 41. Nonglial central nervous system tumors (1 revision)
- 29. Consequences of hypertension (1 revision)
- 20. Nephrosis syndrome: minimal change, membranous glomerulonephritis, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis. (1 revision)
- 111. Risk assessment, management, and communication (1 revision)
- A6. Premature rupture of membranes (1 revision)
- Phaeochromocytoma (1 revision)
- Hand infections (1 revision)